RNAM - Avidity Biosciences, Inc.
72.82
0.020 0.027%
Share volume: 16,757,238
Last Updated: 02-26-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$72.80
0.02
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-09-2024 | 11-07-2024 | 02-27-2025 | 05-08-2025 | 11-10-2025 | 02-23-2026 | |
| Assets | ||||||||
| Total Assets | 951.474 M | 1.347 B | 1.641 B | 1.564 B | 1.459 B | 2.134 B | 1.958 B | |
| Current Assets | 934.474 M | 1.329 B | 1.622 B | 1.542 B | 1.435 B | 1.966 B | 1.798 B | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 18.601 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 18.601 M | 723.295 M | 1.218 B | 1.282 B | 1.126 B | 1.526 B | 1.314 B | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 915.873 M | 575.751 M | 370.187 M | 219.868 M | 254.203 M | 350.158 M | 382.517 M | |
| Total Non-current Assets | 17.000 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 8.655 M | 8.498 M | 9.493 M | 12.670 M | 15.637 M | 21.504 M | 23.333 M | |
| Other Assets | 8.050 M | 10.126 M | 9.412 M | 8.935 M | 8.463 M | 146.688 M | 136.250 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 951.474 M | 1.347 B | 1.641 B | 1.564 B | 1.459 B | 2.134 B | 1.958 B | |
| Total liabilities | 120.575 M | 126.389 M | 137.391 M | 138.936 M | 130.352 M | 247.944 M | 269.450 M | |
| Total current liabilities | 74.955 M | 84.212 M | 91.333 M | 98.018 M | 84.865 M | 169.879 M | 195.446 M | |
| Accounts Payable | 0.000 | 40.924 M | 49.628 M | 69.524 M | 54.189 M | 9.626 M | 12.403 M | |
| Other liabilities | 40.199 M | 4.617 M | 3.797 M | 2.957 M | 0.000 | 45.999 M | 45.313 M | |
| Current long term debt | 3.726 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 5.421 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 40.199 M | 4.617 M | 3.797 M | 2.957 M | 0.000 | 45.999 M | 45.313 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 830.899 M | 1.221 B | 1.503 B | 1.425 B | 1.329 B | 1.886 B | 1.689 B | |
| Common stock | 87.212 M | 1.932 B | 2.287 B | 2.315 B | 2.335 B | 3.225 B | 3.264 B | |
| Retained earnings | -639.619 M | -710.412 M | -790.810 M | -893.066 M | -1.009 B | -1.341 B | -1.578 B |